Table 3.
Characteristics of patients with postoperative sleep disturbance.
| Patient number | Sex/age | Preoperative IGF-1, μg/L | POD 3 IGF-1, μg/L | Treatment |
| GH 1 | F/56 | 494 | 242 | Zolpidem 6.25 mg (from operative day through POD 2), 10 mg (from POD 3 to POD 4) |
| GH 2 | F/56 | 321 | 108 | Quetiapine 6.25 mg (operative day) |
| GH 3 | F/49 | 420 | 256 | Consultation for sleep disturbance (POD 1), no medication |
| GH 4 | F/62 | 501 | 100 | Alprazolam 0.25 mg (POD 6) |
| GH 5 | F/42 | 590 | 327 | Nursing records showed that the patient complained of sleep disturbance (from the operative day through POD 2), no medication |
| GH 6 | F/39 | — | — | Zolpidem 12.5 mg (POD 4), zolpidem 12.5 mg + alprazolam 0.25 mg (POD 5) |
| NF 1 | F/31 | — | — | Zolpidem 10 mg (POD 6) |
| NF 2 | M/56 | — | — | Quetiapine 25 mg (from operative day to POD 2) |